Nanobiotix Files June 2025 Report on Form 6-K
Ticker: NBTX · Form: 6-K · Filed: Jun 10, 2025 · CIK: 1760854
Sentiment: neutral
Topics: sec-filing, form-6k, foreign-private-issuer
TL;DR
Nanobiotix filed its June 6-K, standard procedure for foreign issuers.
AI Summary
Nanobiotix S.A. filed a Form 6-K on June 10, 2025, reporting its activities for the month of June 2025. The company, a foreign private issuer, is based in Paris, France, and operates in the pharmaceutical preparations sector. This filing is made under the Securities Exchange Act of 1934 and indicates the company files annual reports under Form 20-F.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Nanobiotix's ongoing operations and compliance as a foreign private issuer.
Risk Assessment
Risk Level: low — This filing is a routine report for a foreign private issuer and does not contain specific material events or financial disclosures that would indicate increased risk.
Key Players & Entities
- Nanobiotix S.A. (company) — Registrant
- 001-39777 (company) — SEC File Number
- 20250610 (date) — Filing Date
- 60 Rue de Wattignies, Paris, France (company) — Principal Executive Office
FAQ
What type of report is Nanobiotix S.A. filing?
Nanobiotix S.A. is filing a Form 6-K, which is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
When was this Form 6-K filed?
The Form 6-K was filed on June 10, 2025.
Where is Nanobiotix S.A. headquartered?
Nanobiotix S.A. is headquartered at 60 Rue de Wattignies, 75012 Paris, France.
Does Nanobiotix S.A. file annual reports under Form 20-F?
Yes, the filing indicates by check mark that the registrant files annual reports under cover of Form 20-F.
What is the SEC File Number for Nanobiotix S.A.?
The SEC File Number for Nanobiotix S.A. is 001-39777.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 10, 2025 regarding Nanobiotix S.A. (NBTX).